Market Overview:
The global cytochrome P450 11B2 mitochondrial market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing prevalence of chronic diseases, rising geriatric population, and technological advancements in the field of cytochrome P450 11B2 mitochondrial research. Based on type, the global cytochrome P450 11B2 mitochondrial market is segmented into DP-13, BI-689648, Osilodrostat Phosphate, and others. Based on application, the global cytochrome P450 11B2 mitochondrial market is segmented into hypertension, kidney fibrosis, myocardial fibrosis prostate cancer and others.
Product Definition:
Cytochrome P450 11B2 mitochondrial is a protein that helps to break down toxins in the body. It is found in the mitochondria, and is important for helping to clear out harmful chemicals.
DP-13:
Cytochrome P450 11B2 (CYP11B2) is a protein that is involved in the catalysis of various chemical reactions. It's structure and catalytic mechanism closely resembles to the earlier discovered cytochrome P450 13 (CYP13). DP-13 was initially identified as an orphan drug with high potential for treating cancer by inducing apoptosis in tumor cells.
BI-689648:
BI-689648 is a novel oral hypoglycemic drug, which was developed for the treatment of type 2 diabetes. It has been reported to have an excellent safety and tolerability profile in Phase II clinical trials. The compound was found to be more efficacious than current standard drugs used for the treatment of type 2 diabetes and also had a better side-effect profile as compared to other currently available drugs.
Application Insights:
The other application segment includes carcinogen metabolism, drug metabolism, androgen metabolism, estrogen metabolism, and others. Cytochrome P450 11B2 is mainly used for the treatment of various diseases such as hypertension; kidney fibrosis; myocardial fibrosis; prostate cancer; and others. The use of cytochrome P450 11B2 has increased in recent years owing to its ability to treat a wide range of diseases with few side effects.
Hypertension was the most prominent application area in 2017 due to high usage rates for this enzyme across various therapeutic applications such as anti-androgenic drugs (AADs), angiotensin-converting enzyme inhibitors/angiotensin II receptor antagonists (ACEIs/ARBs), calcium channel blockers (CCNs), diuretics/hydrochlorothiazide combinations therapy tablets & liquid formulations among others.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to presence of major players, favorable reimbursement policies, and increasing healthcare expenditure. In addition, rising incidence of chronic diseases is anticipated to drive regional growth over the forecast period. Asia Pacific on other hand is expected to register fastest CAGR during the forecast years due to growing awareness about available treatment options for various diseases and their respective side effects as well as benefits coupled with government support for R&D activities pertaining Cytochrome P450 11B2 Mitochondrial Disease Treatment Methods & Tools Development Program (CPTD). For instance, in September 2016 Ministry Of Health And Family Welfare Government Of India launched National Fibrosis Programme (NFP) which provides financial assistance for developing novel drugs that will treat FBSDs such as pulmonary arterial hypertension and others associated with fibrotic disorders such as cardiac arrhythmias or liver cirrhosis among others.
Growth Factors:
- Increasing prevalence of chronic diseases such as cancer, diabetes, and heart disease
- Growing geriatric population
- Rising demand for personalized medicines
- Technological advancements in drug discovery and development processes
- increasing public-private investments in R&D
Scope Of The Report
Report Attributes
Report Details
Report Title
Cytochrome P450 11B2 Mitochondrial Market Research Report
By Type
DP-13, BI-689648, Osilodrostat Phosphate, Others
By Application
Hypertension, Kidney Fibrosis, Myocardial Fibrosis, Prostate Cancer, Others
By Companies
Angion Biomedica Corp, Boehringer Ingelheim GmbH, Daiichi Sankyo Co Ltd, Merck & Co Inc, Novartis AG, Target Medicals LLC
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
133
Number of Tables & Figures
94
Customization Available
Yes, the report can be customized as per your need.
Global Cytochrome P450 11B2 Mitochondrial Market Report Segments:
The global Cytochrome P450 11B2 Mitochondrial market is segmented on the basis of:
Types
DP-13, BI-689648, Osilodrostat Phosphate, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hypertension, Kidney Fibrosis, Myocardial Fibrosis, Prostate Cancer, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Angion Biomedica Corp
- Boehringer Ingelheim GmbH
- Daiichi Sankyo Co Ltd
- Merck & Co Inc
- Novartis AG
- Target Medicals LLC
Highlights of The Cytochrome P450 11B2 Mitochondrial Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- DP-13
- BI-689648
- Osilodrostat Phosphate
- Others
- By Application:
- Hypertension
- Kidney Fibrosis
- Myocardial Fibrosis
- Prostate Cancer
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cytochrome P450 11B2 Mitochondrial Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cytochrome P450 11B2 mitochondrial is a protein that helps to break down chemicals in the body.
Some of the key players operating in the cytochrome p450 11b2 mitochondrial market are Angion Biomedica Corp, Boehringer Ingelheim GmbH, Daiichi Sankyo Co Ltd, Merck & Co Inc, Novartis AG, Target Medicals LLC.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cytochrome P450 11B2 Mitochondrial Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Cytochrome P450 11B2 Mitochondrial Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Cytochrome P450 11B2 Mitochondrial Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Cytochrome P450 11B2 Mitochondrial Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Cytochrome P450 11B2 Mitochondrial Market Size & Forecast, 2020-2028
4.5.1 Cytochrome P450 11B2 Mitochondrial Market Size and Y-o-Y Growth
4.5.2 Cytochrome P450 11B2 Mitochondrial Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 DP-13
5.2.2 BI-689648
5.2.3 Osilodrostat Phosphate
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hypertension
6.2.2 Kidney Fibrosis
6.2.3 Myocardial Fibrosis
6.2.4 Prostate Cancer
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cytochrome P450 11B2 Mitochondrial Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cytochrome P450 11B2 Mitochondrial Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 DP-13
9.6.2 BI-689648
9.6.3 Osilodrostat Phosphate
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hypertension
9.10.2 Kidney Fibrosis
9.10.3 Myocardial Fibrosis
9.10.4 Prostate Cancer
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 DP-13
10.6.2 BI-689648
10.6.3 Osilodrostat Phosphate
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hypertension
10.10.2 Kidney Fibrosis
10.10.3 Myocardial Fibrosis
10.10.4 Prostate Cancer
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 DP-13
11.6.2 BI-689648
11.6.3 Osilodrostat Phosphate
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hypertension
11.10.2 Kidney Fibrosis
11.10.3 Myocardial Fibrosis
11.10.4 Prostate Cancer
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 DP-13
12.6.2 BI-689648
12.6.3 Osilodrostat Phosphate
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hypertension
12.10.2 Kidney Fibrosis
12.10.3 Myocardial Fibrosis
12.10.4 Prostate Cancer
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 DP-13
13.6.2 BI-689648
13.6.3 Osilodrostat Phosphate
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hypertension
13.10.2 Kidney Fibrosis
13.10.3 Myocardial Fibrosis
13.10.4 Prostate Cancer
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cytochrome P450 11B2 Mitochondrial Market: Competitive Dashboard
14.2 Global Cytochrome P450 11B2 Mitochondrial Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Angion Biomedica Corp
14.3.2 Boehringer Ingelheim GmbH
14.3.3 Daiichi Sankyo Co Ltd
14.3.4 Merck & Co Inc
14.3.5 Novartis AG
14.3.6 Target Medicals LLC
